Lastly, it is important to note that while glutathione is used for its potential skin-lightening effects, the safety and efficacy of this off-label use have not been established, and it may interact with other skin-lightening agents or products
The findings of this meta-analysis suggest that GLP-1 receptor agonists are not associated with an increased risk of gastrointestinal cancers and were not associated with increased gastrointestinal cancer risk and demonstrated pooled estimates below unity for colorectal and liver cancers, findings that should be interpreted as hypothesis-generating rather than confirmatory of cancer prevention (Lingvay et al., 2018
doi: 10.1038/nrdp.2017.13 55 KaliaLVLangAE
This unified mechanism underpins the clinical efficacy observed across all FDA-approved GLP-1 RAs, though individual agents differ in pharmacokinetics and the relative emphasis on gastric versus central pathways
Several forces are working to bring GLP-1 costs down and expand access over the medium term
Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown